Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

Dexcom has received a warning letter from the FDA, after the agency uncovered issues during two inspections of the continuous ...

DexCom (NasdaqGS:DXCM) recently received a warning letter from the FDA, which pointed out issues in manufacturing processes and quality management. While these regulatory developments did not impact ...

Sitting before senators at his confirmation hearing to become commissioner of the FDA, Johns Hopkins surgeon and author ...

Almost 2.4 million Americans wear continuous glucose monitors, or CGMs, to track their blood sugar—and not all of them have ...

A temporary CGM can be the shot in the arm you need to adhere to your diet and exercise plan, but there are also plenty of no ...

The Continuous Glucose Monitoring (CGM) Market Research Report for 2025 delivers a comprehensive analysis of the industry's progress, examining both historical trends and the current market landscape.

Tandem Diabetes Care Inc. reported that its next-generation automated insulin delivery algorithm, Control-IQ+ technology (Control-IQ+), is cleared by the U.S. FDA for use by people with type 2 ...

Statement via Dexcom’s website “Hopefully it is just a short-term, not a long-term thing that we will have to do because we see that if they have that CGM on, it’s more reliable,” said Dr ...

The finding is significant because people can use CGM data to make dietary and lifestyle changes, which may be unnecessary, and the erroneously high readings (indicating glycaemia) could lead them to ...

In other words, for those looking for "forever stocks," it's not a bad idea to look in this sector. And even with a modest sum -- such as $200 -- we can find excellent healthcare corporations to ...

Abbott’s product is competing with Dexcom’s Stelo, which is expected to launch on Amazon soon. Abbott recently launched its Lingo continuous glucose monitoring (CGM) system on Amazon, marking a ...